文献速递心力衰竭与心肌病

循环植物性ω-3脂肪酸与心力衰竭患者预后的关系

Relationship of Circulating Vegetable Omega-3 to Prognosis in Patients With Heart Failure.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

本研究在905例不同病因的稳定性心衰门诊患者中,检测血清磷脂酰胆碱中α-亚麻酸(ALA)水平并随访中位2.4年。与最低四分位(Q1)相比,Q2-Q4组全因死亡或首次心衰住院复合终点风险降低(HR 0.61,95%CI 0.46-0.81),全因死亡、心血管死亡、首次心衰住院及心血管死亡与心衰住院复合终点也均显著降低。

要点

  • 血清磷脂ALA最低四分位心衰患者中期预后更差。
  • ALA较高组全因死亡与首次心衰住院复合风险降低(HR 0.61)。
  • 膳食富含ALA的干预可能值得在低ALA心衰患者中测试。

核心结论

  • 血清磷脂ALA处于最低25%的心衰患者在中位2.4年随访中预后较最高水平者更差。

研究设计与样本

  • 研究纳入905例不同病因的稳定性心衰门诊患者,采用气相色谱法测定血清磷脂ALA,并随访中位2.4年(范围0.02-3年)。

主要发现

  • 随访期间记录140例全因死亡、85例心血管死亡、141例首次心衰住院,全因死亡与首次心衰住院复合终点共238例。
  • 与血清磷脂ALA最低四分位(Q1)相比,Q2-Q4组全因死亡或首次心衰住院复合终点风险降低(HR 0.61;95%CI 0.46-0.81)。
  • Q2-Q4组全因死亡风险降低(HR 0.58;95%CI 0.41-0.82),心血管死亡风险降低(HR 0.51;95%CI 0.32-0.80)。
  • Q2-Q4组首次心衰住院风险降低(HR 0.58;95%CI 0.40-0.84),心血管死亡与心衰住院复合终点风险降低(HR 0.58;95%CI 0.42-0.79)。

临床怎么用

  • 对心衰患者可关注血清磷脂ALA水平,低水平者可能为预后较差的高危人群。
  • 低ALA心衰患者或可作为未来测试富含ALA膳食干预的目标人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is an urgent need for cost-effective strategies to promote quality of life in patients with heart failure (HF). Several studies reported benefits in HF prognosis for marine omega-3 fatty acids and plant-based dietary patterns. OBJECTIVES: The aim of this study was to explore whether dietary alpha-linolenic acid (ALA), the main plant omega-3, relates to a better HF prognosis. METHODS: ALA was determined in serum phospholipids (which reflect long-term dietary ALA intake and metabolism) by gas chromatography in 905 ambulatory patients with HF caused by different etiologies. RESULTS: After a median follow-up of 2.4 years (range: 0.02-3 years), 140 all-cause deaths, 85 cardiovascular (CV) deaths, and 141 first HF hospitalizations (composite of all-cause death and first HF hospitalization, n = 238) were documented. Using Cox regression analyses, we observed that, compared with patients at the lowest quartile of ALA in serum phospholipids (Q1), those at the 3 upper quartiles (Q2-Q4) exhibited a reduction in the risk of composite of all-cause death and first HF hospitalization (HR: 0.61; 95% CI: 0.46-0.81). Statistically significant reductions were observed for all-cause death (HR: 0.58; 95% CI: 0.41-0.82), CV death (HR: 0.51; 95% CI: 0.32-0.80), first HF hospitalization (HR: 0.58; 95% CI: 0.40-0.84), and the composite of CV death and HF hospitalization (HR: 0.58; 95% CI: 0.42-0.79). CONCLUSIONS: HF patients with bottom 25% ALA levels in serum phospholipids had a worse prognosis during a mid-term follow-up compared with those with the highest levels. This might be a target population in whom to test dietary ALA-rich interventions to promote quality of life.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Lázaro, Lupón, Cediel, et al. Relationship of Circulating Vegetable Omega-3 to Prognosis in Patients With Heart Failure. J Am Coll Cardiol. 2022. PMID: 36302588. doi:10.1016/j.jacc.2022.08.771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。